欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IT/V/0121/001
药品名称Mastiplan LC
活性成分
    • cefapirin sodium salt 300.0 mg
    • prednisolone 20.0 mg
剂型Intramammary suspension
上市许可持有人Intervet International BV
参考成员国 - 产品名称Italy (IT)
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
      Mastiplan LC
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Mastiplan LC, 300 mg/20 mg (Cefapirin/Prednisolone), intramammary suspension for lactating cows
    • France (FR)
      MASTIPLAN LC (12451)
    • Spain (ES)
      MASTIPLAN
    • Portugal (PT)
    • Greece (GR)
    • Poland (PL)
    • Hungary (HU)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Bulgaria (BG)
许可日期2007/02/28
最近更新日期2023/06/30
药物ATC编码
    • QJ51RV01 antibacterials and corticosteroids
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Fixed combination Art 13b Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase